{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T05:00:38Z","timestamp":1780203638522,"version":"3.54.0"},"reference-count":51,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cervical cancer remains a major public health challenge worldwide and in Poland, where mortality rates are among the highest in the European Union. Persistent infection with high-risk human papillomavirus (hrHPV), particularly genotype HPV16, plays a central role in cervical carcinogenesis. This study aimed to evaluate the regional variability of hrHPV prevalence and genotype distribution in Poland and to assess its potential implications for cervical cancer incidence and prevention strategies. A systematic literature review was conducted using PubMed, Scopus, and Google Scholar to identify studies published up to May 2025 reporting hrHPV prevalence and genotypes among Polish women. Eligible studies included population-based cohorts, women undergoing screening, and patients with cervical lesions or cancer. The analysis revealed substantial heterogeneity in hrHPV prevalence and genotype distribution across regions and study populations. Nationwide data indicate high overall HPV prevalence (up to 50.9%), with HPV16 consistently dominating, followed by HPV31, HPV51, HPV52, and HPV66. Regional differences were observed, including a higher prevalence of HPV51 in southern Poland and HPV56 and HPV45 in central regions. Studies in women with abnormal cytology or cervical cancer showed markedly higher hrHPV prevalence (often &gt;90%), with HPV16 predominating in high-grade lesions and invasive cancer. These findings confirm the dominant oncogenic role of HPV16 while highlighting significant regional variability in other hrHPV genotypes. Such differences may influence the effectiveness of screening and vaccination programs. Strengthening standardized, regionally stratified HPV surveillance is essential to optimize cervical cancer prevention and tailor public health interventions in Poland.<\/jats:p>","DOI":"10.3390\/cancers18111774","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:06:56Z","timestamp":1780049216000},"page":"1774","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is There Geographic Variation in Poland in the Distribution of Specific High-Risk HPV Genotypes in Normal Cervical Epithelium, Dysplastic Lesions, and Cervical Cancers?"],"prefix":"10.3390","volume":"18","author":[{"given":"Beata","family":"Biesaga","sequence":"first","affiliation":[{"name":"Department of Tumor Pathology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w Branch, 31-115 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mucha-Ma\u0142ecka","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w Branch, 31-115 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kruczak","sequence":"additional","affiliation":[{"name":"Department of Tumor Pathology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w Branch, 31-115 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktor","family":"Szatkowski","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Krak\u00f3w Branch, 31-115 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5603\/njo.99065","article-title":"Cancer incidence and mortality in Poland in 2023","volume":"74","author":"Didkowska","year":"2024","journal-title":"Nowotwory. J. Oncol."},{"key":"ref_3","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012). Biological agents. IARC Monographs on the evaluation of Carcinogenic Risks to Humans, IARC."},{"key":"ref_4","unstructured":"IARC (2007). Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC."},{"key":"ref_5","unstructured":"World Health Organization (2024). Target Product Profiles for Human Papillomavirus Screening Tests to Detect Cervical Precancer and Cancer, World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100955","DOI":"10.1016\/j.lanmic.2024.100955","article-title":"Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: A systematic review and meta-analysis","volume":"6","author":"Osmani","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis","volume":"7","author":"Diaz","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of human papillomavirus vaccination on cervical cancer incidence in England","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: A systematic review of 10 years of real-world evidence","volume":"63","author":"Garland","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: A systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human Papillomavirus Types in 115,789 HPV-Positive Women: A Meta-Analysis from Cervical Infection to Cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study","volume":"11","author":"Quint","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.33033","article-title":"Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention","volume":"147","author":"Pinheiro","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"H59","DOI":"10.1016\/j.vaccine.2013.03.029","article-title":"Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe","volume":"31","author":"Poljak","year":"2013","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2024.06.030","article-title":"Treatment characteristics, HPV genotype distribution and risk of subsequent disease among women with high-grade cervical intraepithelial neoplasia in Europe: A systematic literature review","volume":"300","author":"Reuschenbach","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.27713","article-title":"HERACLES\/SCALE Study Group. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe","volume":"132","author":"Tjalma","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_24","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., and de Sanjos\u00e9, S. (2023). Human Papillomavirus and Related Diseases in Germany, ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Summary Report 10 March 2023."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejca.2004.07.005","article-title":"Prevalence of human papillomavirus infection in women in Turin, Italy","volume":"41","author":"Ronco","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Piana, A., Sotgiu, G., Castiglia, P., Pischedda, S., Cocuzza, C., Capobianco, G., Marras, V., Dessole, S., and Muresu, E. (2011). Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy. BMC Public Health, 11.","DOI":"10.1186\/1471-2458-11-785"},{"key":"ref_27","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., and de Sanjos\u00e9, S. (2023). Human Papillomavirus and Related Diseases in Spain, ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Summary Report 10 March 2023."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"362371","DOI":"10.5603\/GP.2020.0075","article-title":"COLPOSCOPY 2020\u2014COLPOSCOPY PROTOCOLS: A Summary of the Clinical Experts Consensus Guidelines of the Polish Society of Colposcopy and Cervical Pathophysiology and the Polish Society of Gynaecologists and Obstetricians","volume":"91","author":"Jach","year":"2020","journal-title":"Ginekol. Pol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.5603\/gpl.101436","article-title":"Baseline data on distribution of human papillomavirus (HPV) genotypes in cervical samples of gynecological patients before implementation of population-based HPV vaccination program in Poland","volume":"95","author":"Macios","year":"2024","journal-title":"Ginekol. Pol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Przybylski, M., Pruski, D., Wszo\u0142ek, K., de Mezer, M., \u017burawski, J., Jach, R., and Millert-Kali\u0144ska, S. (2023). Prevalence of HPV and Assessing Type-Specific HPV Testing in Cervical High-Grade Squamous Intraepithelial Lesions in Poland. Pathogens, 12.","DOI":"10.3390\/pathogens12020350"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejca.2007.12.001","article-title":"Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland","volume":"44","author":"Bardin","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.18388\/abp.2008_3028","article-title":"Genotype-specific human papillomavirus detection in cervical smears","volume":"55","author":"Szostek","year":"2008","journal-title":"Acta Biochim. Pol."},{"key":"ref_33","first-page":"664","article-title":"Genotypowanie wirus\u00f3w brodawczaka ludzkiego u kobiet z CIN 1 [Human papilloma virus genotyping in women with CIN 1]","volume":"81","author":"Pruski","year":"2010","journal-title":"Ginekol. Pol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2021.11.427","article-title":"HPV RNA and DNA testing in Polish women screened for cervical cancer\u2014A single oncological center study","volume":"268","author":"Bebyn","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kiwerska, K., Jozefiak, A., Markowska, J., Kedzia, W., Jackowska, J., and Wierzbicka, M. (2019). Oral-genital human papillomavirus infection in Polish couples: Frequent detection of HPV 42. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-018-3645-0"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12253-014-9877-4","article-title":"HPV-type distribution and reproducibility of histological diagnosis in cervical neoplasia in Poland","volume":"21","author":"Nowakowski","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"ref_37","first-page":"740","article-title":"Wyst\u0119powanie DNA wirusa HPV u pacjentek z rakiem szyjki macicy w regionie gda\u0144skim. [The incidence of human papilloma virus (HPV) DNA in patients with cervical carcinoma from Gdansk region]","volume":"73","author":"Liss","year":"2002","journal-title":"Ginekol. Pol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1177\/0956462418824441","article-title":"Patterns of incident genital human papillomavirus infection in women: A literature review and meta-analysis","volume":"30","author":"Wheeler","year":"2019","journal-title":"Int. J. STD AIDS"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ijc.27828","article-title":"Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis","volume":"133","author":"Rositch","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12985-025-02790-y","article-title":"Age-related distribution of human papillomavirus genotypes in women with cervical squamous cell carcinoma from Linyi, China, 2015\u20132023","volume":"22","author":"Wang","year":"2025","journal-title":"Virol. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/cncy.22573","article-title":"The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases","volume":"130","author":"Tao","year":"2022","journal-title":"Cancer Cytopathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ajcp\/aqab181","article-title":"Nationwide prevalence and genotype distribution of high-risk human papillomavirus infection in China","volume":"157","author":"Zeng","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zhong, F., Li, Z., Sun, Y., Xiao, Y., Li, J., Zhou, X., Cong, Q., Sui, L., Tao, X., and Zhao, C. (2023). HPV genotyping of cervical histologic specimens of 61, 422 patients from the largest women hospital in China. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1161631"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"918","DOI":"10.7326\/M21-3798","article-title":"Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the United States, 2003 to 2018","volume":"175","author":"Rosenblum","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1017\/S0950268823000213","article-title":"Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection","volume":"151","author":"Li","year":"2023","journal-title":"Epidemiol. Infect."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cid\/ciw533","article-title":"Substantial decline in vaccine-type Human Papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a community","volume":"63","author":"Kahn","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e20151968","DOI":"10.1542\/peds.2015-1968","article-title":"Prevalence of HPV after introduction of the vaccination program in the United States","volume":"137","author":"Markowitz","year":"2016","journal-title":"Pediatrics"},{"key":"ref_48","unstructured":"Polish Ministry of Health (2023, May 09). Zalecenia Ministra Zdrowia Dotycz\u0105ce Realizacji Szczepie\u0144 Przeciw Ludzkiemu Wirusowi Brodawczaka (HPV) w Ramach Powszechnego Programu Szczepie\u0144, Available online: https:\/\/www.gov.pl\/attachment\/a7795344-3096-464e-8a22-beea93d06a75."},{"key":"ref_49","first-page":"189","article-title":"The HPV prevention and control program in Poland: Progress and the way forward","volume":"33","author":"Nowakowski","year":"2024","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Poniewierza, P., \u015aniadecki, M., Musielak, O., Raza, A., Safari, Y., Pi\u0105tek-Dalewska, O., Danielkiewicz, M., Mazur, A., Amerek, Z., and Khan, S.R. (2025). Initial Coverage and Regional Disparities of the National HPV Vaccination Program in Poland: A Cross-Sectional Analysis. Healthcare, 13.","DOI":"10.3390\/healthcare13243281"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jasc.2025.03.006","article-title":"Human papillomavirus genotype distribution and its correlation with intraepithelial neoplasia, vaccination, and ethnicity","volume":"14","author":"Sun","year":"2025","journal-title":"J. Am. Soc. Cytopathol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1774\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:16:50Z","timestamp":1780201010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18111774"],"URL":"https:\/\/doi.org\/10.3390\/cancers18111774","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}